Compare WVE & CSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | CSGS |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2015 | 1996 |
| Metric | WVE | CSGS |
|---|---|---|
| Price | $13.25 | $80.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 6 |
| Target Price | $30.87 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 2.2M | 280.8K |
| Earning Date | 05-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.98 |
| Revenue | $3,704,000.00 | ★ $996,810,000.00 |
| Revenue This Year | N/A | $5.45 |
| Revenue Next Year | $119.93 | $3.02 |
| P/E Ratio | ★ N/A | $40.37 |
| Revenue Growth | ★ 149.43 | 13.91 |
| 52 Week Low | $5.28 | $54.65 |
| 52 Week High | $21.73 | $80.67 |
| Indicator | WVE | CSGS |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 65.21 |
| Support Level | $12.53 | $79.41 |
| Resistance Level | $14.56 | $80.22 |
| Average True Range (ATR) | 0.79 | 0.22 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 26.10 | 91.80 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.